new glp 1 agonist novo nordisk GLP-1s for Alzheimer's: announces trial conclusion Novo Nordisk's weight-loss pill wins
Description
There is no evidence that supplementing will restart a weight plateau, but you made need some none the less
Activation of glucagon-like peptide-1 receptor in microglia exerts protective effects against sepsis-induced encephalopathy via attenuating endoplasmic reticulum stress-associated inflammation and apoptosis in a mouse model of sepsis
Sodium-glucose cotransport protein 2 inhibitors in patients with type 2 diabetes and acute kidney disease
Ther Adv Endocrinol Metab (2014) 5:348
However, the dedicated HF trials were not designed to address atherosclerotic CVD outcomes
